Medication info

Olmesartan Medoxomil Tablets 20 mg

Prescription medicationTabletOralExpired
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Kolon Pharmaceutical Co., Ltd.
Appearance
White, round, film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 201100947 · Approved 2011.02.25

This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after initiation of treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while carefully monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
<Pediatrics> The safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Kolon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is treated to lower blood pressure to a normal range, reducing the strain on the cardiovascular system and the risk of complications. This medication helps control blood pressure in essential hypertension, preventing severe complications such as heart disease or stroke.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after initiation of treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this medicine alone, it may be administered in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. In patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while carefully monitoring their condition. <Elderly patients> No dose adjustment is necessary when administering this medicine to elderly patients aged 65 years or older. Although no overall differences in the efficacy and safety of this medicine have been observed between elderly and younger patients, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. For patients with moderate hepatic impairment, the recommended initial dose is 10mg once daily, and the dose may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

<Pediatrics> The safety and efficacy in pediatric patients have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any components of this medication, pregnant or nursing women, patients undergoing kidney dialysis, patients with severe liver impairment, or those with biliary obstruction should not take this medication. When this medication is first administered to patients with reduced blood volume or salt, hypotension may occur, so their condition should be monitored closely, and appropriate measures taken if hypotension occurs. Patients with impaired kidney function or kidney transplant recipients should regularly check their kidney function and blood potassium levels through blood tests while taking this medication, and it is not recommended for patients with severe kidney impairment. Due to the risk of hyperkalemia, patients with risk factors for hyperkalemia should frequently check their blood potassium levels. This medication can cause dizziness, so caution is required when operating hazardous machinery or driving. This medication may cause various adverse reactions, with dizziness being the most common symptom. Rarely, angioedema or hepatic dysfunction, hyperkalemia, and acute renal failure may occur, so immediate consultation with a healthcare professional is necessary if abnormal symptoms arise. Chronic diarrhea and weight loss have been seldom reported in chronic malabsorption-like intestinal diseases, and this medication should be discontinued if such symptoms occur. When taken with potassium-sparing diuretics or potassium supplements, blood potassium levels may rise dangerously, so caution is advised in such cases. Taking this medication with other antihypertensive agents may enhance the hypotensive effect, so it should be taken according to the doctor's instructions. This medication should not be administered to pregnant women, as it may cause serious harm to the fetus, and nursing mothers should consider discontinuing either the medication or breastfeeding due to potential adverse reactions in infants. Safety has not been established in pediatric patients, so it is advisable not to use it in children. Elderly patients may have increased drug concentration in the body, so caution is required when taking it. In cases of overdose, symptoms such as hypotension and palpitations may occur, and appropriate treatment should be administered based on symptoms. Long-term use of this medication has not significantly reported carcinogenicity or genotoxicity risks, but it is important to regularly monitor individual reactions as the potential for adverse reactions may vary.

Side effects

  • Dizziness
  • back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • flu-like symptoms
Show 36 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • angioedema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • hypertension
  • epistaxis
  • asthma

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air or moisture from entering, and keep it at room temperature between 1 and 25 degrees Celsius. Storing it this way helps maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

White, round, film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.